Older Age and High α-Fetoprotein Predict Higher Risk of Hepatocellular Carcinoma in Chronic Hepatitis-B-Related Cirrhotic Patients Receiving Long-Term Nucleos(t)ide Analogue Therapy

Background: Nucleos(t)ide analogues (NUCs) were proved to reduce hepatocellular carcinoma (HCC) development in chronic hepatitis B (CHB) patients, but data were limited on their efficacy in cirrhotic CHB patients. Methods: A total of 447 cirrhotic CHB patients treated with tenofovir/entecavir were r...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yuh-Ying, Lin, Chih-Lang, Weng, Cheng-Hao, Chang, Pei-Hung, Chien, Cheng-Hung, Huang, Kuang-Chen, Hua, Man-Chin, Hu, Ching-Chih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497657/
https://www.ncbi.nlm.nih.gov/pubmed/36140487
http://dx.doi.org/10.3390/diagnostics12092085

Ejemplares similares

Ejemplares similares